TETEC AG = cell-based therapy innovations for tomorrow’s health
A passion for science and research as well as the drive to sustainably improve people’s health and quality of life – those were TETEC AG's founding principles in the year 2000.
We now have more than 20 years of experience and are the European market leader in cartilage cell therapy, ATMPs (advanced therapy medicinal products) and suitable biomaterials. At TETEC AG's headquarters in Reutlingen, our more than 130 employees work daily in interdisciplinary teams on the therapy solutions of tomorrow.
Our innovative research and development program includes novel treatment options, including for osteoarthritis and chronic inflammatory diseases.